GSK and Clover Collaborate to Begin Phase 1 COVID-19 Vaccine trials
 
GlaxoSmithKline has begun a COVID-19 clinical trial with China’s Clover Biopharmaceuticals, combining its booster with the biotech’s early-stage vaccine. 
$GSK $CLV #coronastocks #stocks https://t.co/2C73E8RhSE https://t.co/YyiVSl1KoB